Kahn RS - Search Results

1

The MCPP challenge test in schizophrenia: hormonal and behavioral responses.

Iqbal N, Asnis GM, Wetzler S, Kahn RS, Kay SR, van Praag HM. Iqbal N, et al. Among authors: kahn rs. Biol Psychiatry. 1991 Oct 15;30(8):770-8. doi: 10.1016/0006-3223(91)90233-c. Biol Psychiatry. 1991. PMID: 1751620 Clinical Trial.

2

Serotonin function in schizophrenia: effects of meta-chlorophenylpiperazine in schizophrenic patients and healthy subjects.

Kahn RS, Siever LJ, Gabriel S, Amin F, Stern RG, DuMont K, Apter S, Davidson M. Kahn RS, et al. Psychiatry Res. 1992 Jul;43(1):1-12. doi: 10.1016/0165-1781(92)90136-q. Psychiatry Res. 1992. PMID: 1332094 Clinical Trial.

3

Effect of m-chlorophenylpiperazine on plasma arginine-vasopressin concentrations in healthy subjects.

Kahn RS, Kling MA, Wetzler S, Asnis GM, van Praag H. Kahn RS, et al. Psychopharmacology (Berl). 1992;108(1-2):225-8. doi: 10.1007/BF02245312. Psychopharmacology (Berl). 1992. PMID: 1410142 Clinical Trial.

4

Functional interrelationship of serotonin and norepinephrine: cortisol response to MCPP and DMI in patients with panic disorder, patients with depression, and normal control subjects.

Asnis GM, Wetzler S, Sanderson WC, Kahn RS, van Praag HM. Asnis GM, et al. Among authors: kahn rs. Psychiatry Res. 1992 Jul;43(1):65-76. doi: 10.1016/0165-1781(92)90142-p. Psychiatry Res. 1992. PMID: 1438618 Clinical Trial.

5

Effect of m-chlorophenylpiperazine on plasma homovanillic acid concentrations in healthy subjects.

Kahn RS, Knott P, Gabriel S, DuMont K, Mastroianni L, Davidson M. Kahn RS, et al. Biol Psychiatry. 1992 Dec 1;32(11):1055-61. doi: 10.1016/0006-3223(92)90068-b. Biol Psychiatry. 1992. PMID: 1467386 Clinical Trial.

6

A dose-response study of intravenous m-chlorophenylpiperazine in normal subjects.

Kalus O, Wetzler S, Kahn RS, Asnis GM, van Praag HM. Kalus O, et al. Among authors: kahn rs. Psychopharmacology (Berl). 1992;106(3):388-90. doi: 10.1007/BF02245423. Psychopharmacology (Berl). 1992. PMID: 1533289 Clinical Trial.

7

Nocturnal growth hormone secretion in schizophrenic patients and healthy subjects.

Kahn RS, Davidson M, Hirschowitz J, Stern RG, Davis BM, Gabriel S, Moore C, Davis KL. Kahn RS, et al. Psychiatry Res. 1992 Feb;41(2):155-61. doi: 10.1016/0165-1781(92)90107-e. Psychiatry Res. 1992. PMID: 1574542

8

Panic disorder: a biological perspective.

Kahn RS, van Praag HM. Kahn RS, et al. Eur Neuropsychopharmacol. 1992 Mar;2(1):1-20. doi: 10.1016/0924-977x(92)90031-3. Eur Neuropsychopharmacol. 1992. PMID: 1638169 Review.

9

Pituitary hormone responses to meta-chlorophenylpiperazine in panic disorder and healthy control subjects.

Kahn RS, Wetzler S, Asnis GM, Kling MA, Suckow RF, van Praag HM. Kahn RS, et al. Psychiatry Res. 1991 Apr;37(1):25-34. doi: 10.1016/0165-1781(91)90103-v. Psychiatry Res. 1991. PMID: 1650487

10

m-Chlorophenylpiperazine as a probe of serotonin function.

Kahn RS, Wetzler S. Kahn RS, et al. Biol Psychiatry. 1991 Dec 1;30(11):1139-66. doi: 10.1016/0006-3223(91)90184-n. Biol Psychiatry. 1991. PMID: 1663792 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,145 results

Search Page

Filters